What's new in atopic dermatitis: JEADV updated guidelines Dr Manoj Kumar Nayak8 Sep 2021 4:30 AM GMTWhat's new in atopic dermatitis: JEADV updated guidelines Atopic dermatitis (AD) is a chronic inflammatory multifactorial cutaneous disorder that ...
Abrocitinib proves efficacious in atopic dermatitis : JAMA study Dr Manoj Kumar Nayak2 Sep 2021 3:30 AM GMTAbrocitinib proves efficacious in atopic dermatitis finds a new study published in JAMA. Atopic dermatitis (AD) is a severely pruritic chronic,...
Difamilast ointment well tolerated in paediatric patients with atopic dermatitis, Study finds Dr. Nandita Mohan19 Aug 2021 3:30 AM GMTIn atopic dermatitis (AD), phosphodiesterase 4 (PDE4) inhibition reduces proinflammatory mediators and cytokines. Difamilast is a new selective PDE4 ...
Atopic Dermatitis linked to increased incidence of hypertension: Study Dr. Nandita Mohan14 Aug 2021 3:45 AM GMTAtopic dermatitis (AD), particularly moderate-to-severe disease, was associated with increased hypertension compared to healthy controls, but lower...
Compared to Dupilumab Upadacitinib rapidly improves itching and clears skin in atopic dermatitis: JAMA Dr Manoj Kumar Nayak9 Aug 2021 3:30 AM GMTUpadacitinib vs Dupilumab in adult atopic dermatitis (AD) : JAMA studyAtopic dermatitis is a severely pruritic relapsing disorder with multiple...
Air pollutants linked to increased risk of Atopic dermatitis: AAD study Dr Satabdi Saha28 July 2021 3:30 AM GMTLong-term exposure to air pollutants, including gases and particulate matter, is an independent risk factor for developing Atopic dermatitis (AD),...
Autologous Bacteriotherapy Effective For Treatment of Atopic Dermatitis: Study MD Bureau16 July 2021 3:00 AM GMTA bacteriotherapy with an autologous strain of bacteria may safely be used in patients with AD to improve disease severity. USA: A bacteriotherapy ...
Probiotic mixture reduces gut inflammation in children with atopic dermatitis Dr. Nandita Mohan23 Jun 2021 4:00 AM GMTAccording to recent research, it has been established that the oral administration of the probiotic mixture was effective in reducing clinical...
Exclude patients with history of TB from Baricitinib clinical study for Atopic Dermatitis: CDSCO panel tells Eli Lilly Medical Dialogues Team15 Jun 2021 11:26 AM GMTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has asked Eli Lilly to conduct a clinical...
Dupilumab may Raise Risk of Ocular Disease in Atopic Dermatitis Patients: Study Josepha James8 Jun 2021 3:45 AM GMTDupilumab is the first human monoclonal antibody approved for the treatment of atopic dermatitis (AD). However, a recent study suggests that the use...
Ruxolitinib shows promise in managing atopic dermatitis: Study Dr Satabdi Saha3 Jun 2021 3:30 AM GMTIn a recent development, researchers have highlighted that Ruxolitinib (RUX) cream has shown anti-inflammatory and prompt antipruritic effects with...
Oral upadacitinib an effective treatment option for eczema, study shows Hina Zahid27 May 2021 3:00 AM GMTUSA: Monotherapy with oral medication upadacitinib could be a potential treatment and has a positive benefit-risk profile in people with...
